CASE Op-Ed: Benefits of CVS/Aetna Merger Likely Elusive for Patients and Consumers
Gerard Scimeca, CASE Chairman December 11, 2017 – http://bit.ly/2AbxGBC With the recent $69 billion acquisition of Aetna insurance by CVS —...
Gerard Scimeca, CASE Chairman December 11, 2017 – http://bit.ly/2AbxGBC With the recent $69 billion acquisition of Aetna insurance by CVS —...
http://bit.ly/2EsfFSE Matthew Kandrach, CASE President Government programs don’t have a great track record of coming in under budget, but Medicare...
Read full article here: by CASE President Matthew Kandrach Pharmacy Benefit Managers (PBMs), the goliath health insurance middle-men wedged between...
CASE Read of the Day
Could EVs compete in a free market?
CASE Read of the Day
Another undesirable “record” for Americans struggling with the economy. #Bidenomics
.@ICBA's recent polling reveals that Americans are NOT in favor of the #CCCA. 55% of Americans believe the bill would have a negative effect on the economy. #OpposeDurbinMarshall
.@sallypipes: “Heavy-handed market interventions have stifled innovation and reduced the availability of life-saving medicines every place they've been tried.” Dems' #IRA jeopardizes patient access to lifesaving treatments & medications. @HouseCommerce